11: Antibiotic resistance

Medical Journal of Australia

Volumn 177, Issue 6, 2002, Pages 325-329

  Collignon, Peter J ^a,b  

^a CANBERRA HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFALEXIN; CEFAZOLIN; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DICLOXACILLIN; DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN; GLYCOPEPTIDE; LINEZOLID; MEROPENEM; METICILLIN; PENICILLIN BINDING PROTEIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RETINOIC ACID; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ACNE; ANAMNESIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AUSTRALIA; BACTERIAL INFECTION; BACTERIUM ISOLATION; BRONCHITIS; CLINICAL PROTOCOL; COMMON COLD; CROSS RESISTANCE; DEVICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG RESEARCH; DRUG USE; GENE TRANSFER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE PLANNING; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MAXILLA SINUSITIS; NONHUMAN; OPTIMAL DRUG DOSE; OTITIS MEDIA; PNEUMONIA; RESPIRATORY TRACT INFECTION; REVIEW; SALMONELLOSIS; SANITATION; SEPTICEMIA; SORE THROAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 0037120582     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04794.x     Document Type: Review

References (31)

1. Waldvogel F. Staphylococcus aureus (including toxic shock syndrome). In: Mandell G, Bennett J, Dolin R, editors. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000: 2065-2092.
2. Collignon P, Gosbell I, Vickery A, et al. Community-acquired methicillin-resistant Staphylococcus aureus in Australia. Australian Group on Antimicrobial Resistance. Lancet 1998; 352: 145-146.
3. Gosbell IB, Mercer JL, Neville SA, et al. Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections. Med J Aust 2001; 174: 627-630.
4. Paterson D. Reduced susceptibility of Staphylococcus aureus to vancomycin - A review of current knowledge. Commun Dis Intell 1999; 24: 69-73.
5. Ward P, Johnson P, Grabsch E, et al. Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust 2001; 175: 480-483.
6. Edmond MB, Ober JF, Dawson JD, et al. Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality. Clin Infect Dis 1996; 23: 1234-1239.
7. Collignon P. Vancomycin-resistant enterococci and use of avoparcin in animal feed: Is there a link? Med J Aust 1999; 171: 144-146.
8. Gonzalez RD, Schreckenberger PC, Graham MB, et al. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 2001; 357: 1179.
9. Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001; 358: 207-208.
10. Riley T, Webbs S, Cadwallader H, et al. Outbreak of gentamicin-resistant Acinetobacter baumanii in an intensive care unit: Clinical, epidemiological and microbiological features. Pathology 1996; 28: 359-363.
11. McDonald LC, Rossiter S, Mackinson C, et al. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. N Engl J Med 2001; 345: 1155-1160.
12. The use of antibiotics in food-producing animals: Antibiotic-resistant bacteria in animals and humans. Report of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR). Canberra: Office of National Health and Medical Research, Oct 1999. http://www.health.gov.au/pubs/jetacar.htm
13. Interagency Task Force on Antimicrobial Resistance, Co-chairs: Centers for Disease Control and Prevention, Food and Drug Administration, National Institutes of Health, Agency for Healthcare Research and Quality, Health Care Financing Administration, Health Resources and Services Administration, Department of Agriculture, Department of Defense, Department of Veterans Affairs. Environmental Protection Agency. A public health action plan to combat antimicrobial resistance, 2001. http://www.cdc.gov/drugresistance/actionplan/html/index.htm
14. World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. 2001. Available at http://www.who.int/emc/amrpdfs/WHO_Global_Stategy_English.pdf
15. Sherley M, Gordon DM, Collignon PJ. Variations in antibiotic resistance profile in Enterobacteriaceae isolated from wild Australian mammals. Environ Microbiol 2000; 2: 620-631.
16. Rountree P, Beard M. Hospital strains of Staphylococcus aureus with particular reference to methicillin-resistant strains. Med J Aust 1968; 26: 1163-1168.
17. Townsend DE, Ashdown N, Bradley JM, et al. "Australian" methicillin-resistant Staphylococcus aureus in a London hospital? Med J Aust 1984; 141: 339-340.
18. Dutka-Malen S, Leclercq R, Coutant V, et al. Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrob Agents Chemother 1990; 34: 1875-1879.
19. Sievert DM, Boulton ML, Stoltman G, et al. Staphylococcus aureus resistant to vancomycin - United States. MMWR Morb Mortal Wkly Rep 2002; 51: 565-567.
20. Collignon PJ, Turnidge JD. Antibiotic resistance in Streptococcus pneumoniae. Med J Aust 2000; 173 Suppl: S58-S64.
21. Therapeutic Guidelines Ltd. Therapeutic Guidelines: Antibiotic. Version 11. 2000: 169.
22. Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis (Cochrane Review). Cochrane Library 2001; 4. Oxford: Update Software.
23. Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat (Cochrane Review). Cochrane Library 2001; 4. Oxford: Update Software.
24. Nasrin D, Collignon P, Roberts L, et al. Effect of β-lactam antibiotic use in children on pneumococcal resistance to penicillin: Prospective cohort study. BMJ 2002; 324: 28-30.
25. McIntyre PB, Chey T, Smith WT. The impact of vaccination against invasive Haemophilus influenzae type b disease in the Sydney region. Med J Aust 1995; 162: 245-248.
26. Spelman DW. Hospital-acquired infections. Med J Aust 2001; 176: 286-291.
27. Collignon P. Hospital-acquired infections: A skeleton in the closet of medical progress. Med J Aust 1995; 163: 228.
28. Nichols R. Prophylaxis for surgical infections. In: Grobach S, Bartlett J, Blacklow N, editors. Infectious Diseases. Philadelphia: WB Saunders, 1992: 393-403. 1: Management plan for antibiotic resistance.
29. Glasziou PP, Del Mar CB, Sanders SL, Hayem M. Antibiotics for acute otitis media in children (Cochrane Review). Cochrane Library 2001; 4. Oxford: Update Software.
30. Arroll B, Kenealy T. Antibiotics for the common cold (Cochrane Review). Cochrane Library 2001; 4. Oxford: Update Software.
31. Williams JW, Aguilar C, Makela M, et al. Antibiotics for acute maxillary sinusitis (Cochrane Review). Cochrane Library 2001; 4. Oxford: Update Software.